Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Authors: Lenton, Douglas, Taper, John, Presgrave, Peter, Butler, Jason, Mollee, Peter, Kannourakis, George, Steer, Christopher, Verner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza A., Lee, Hui-Peng, Cochrane, Tara, Cheah, Chan Yoon, Filshie, Robin, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop K., Brown, Christina, Murphy, Nicholas, Curnow, Jennifer, Lee, Kenneth, Gandhi, Maher K., Walia, Mannu, Butcher, Belinda E., Trotman, Judith

Source: In Blood Advances 12 November 2024 8(21):5674-5682

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

Authors: Loo, Sun, Roberts, Andrew W., Anstee, Natasha S., Kennedy, Glen A., He, Simon, Schwarer, Anthony P., Enjeti, Anoop K., D’Rozario, James, Marlton, Paula, Bilmon, Ian A., Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe, Hiwase, Devendra K., Iland, Harry J., Murphy, Nick, Ramanathan, Sundra, Reynolds, John, Ong, Doen Ming, Tiong, Ing Soo, Wall, Meaghan, Murray, Michael, Rawling, Tristan, Leadbetter, Joanna, Rowley, Leesa, Latimer, Maya, Yuen, Sam, Ting, Stephen B., Fong, Chun Yew, Morris, Kirk, Bajel, Ashish, Seymour, John F., Levis, Mark J., Wei, Andrew H.

Source: In Blood 7 December 2023 142(23):1960-1971

Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study

Authors: Odutola, Michael K., van Leeuwen, Marina T., Turner, Jennifer, Bruinsma, Fiona, Seymour, John F., Prince, H. Miles, Milliken, Samuel T., Hertzberg, Mark, Trotman, Judith, Opat, Stephen S., Lindeman, Robert, Roncolato, Fernando, Verner, Emma, Harvey, Michael, Tiley, Campbell, Underhill, Craig R., Benke, Geza, Giles, Graham G., Vajdic, Claire M.

Source: In Cancer Epidemiology October 2022 80

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study

Authors: Cull, Gavin, Burger, Jan A., Opat, Stephen, Gottlieb, David, Verner, Emma, Trotman, Judith, Marlton, Paula, Munoz, Javier, Johnston, Patrick, Simpson, David, Stern, Jennifer C., Prathikanti, Radha, Wu, Kenneth, Novotny, William, Huang, Jane, Tam, Constantine S.

Source: British journal of haematology. 196(5):1209-1218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100142022931.0x000001&indx=1&recIds=ETOCvdc_100142022931.0x000001

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Authors: Tam, Constantine S, Brown, Jennifer R, Kahl, Brad S, Ghia, Paolo, Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Shadman, Mazyar, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M, Flinn, Ian W, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C, Cohen, Aileen, Huang, Jane, Robak, Tadeusz, Hillmen, Peter

Source: Lancet oncology. 23(8):1031-1043

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184428950.0x000001&indx=1&recIds=ETOCvdc_100184428950.0x000001

Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

Authors: Wight, Joel, Hamad, Nada, Campbell, Belinda A., Ku, Matthew, Lee, Kenneth, Rose, Hannah, Armytage, Tasman, Latimer, Maya, Lee, Hui‐Peng, Lee, Sze‐Ting, Dickinson, Michael, Khor, Richard, Verner, Emma

Source: Internal medicine journal. 52(9):1609-1623

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100160608304.0x000001&indx=1&recIds=ETOCvdc_100160608304.0x000001

Gender differences using online auctions within a generation Y sample: An application of the Theory of Planned Behaviour

Authors: McLaughlin, Christopher, McCauley, Laura Bradley, Prentice, Garry, Verner, Emma-Jayne, Loane, Sharon

Source: In Journal of Retailing and Consumer Services September 2020 56

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Authors: Verner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza A., Lee, Hui-Peng, Cochrane, Tara, Cheah, Chan Yoon, Filshie, Robin, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop K., Brown, Christina, Murphy, Nicholas, Curnow, Jennifer, Lee, Kenneth, Gandhi, Maher K., Walia, Mannu, Butcher, Belinda E., Trotman, Judith, Lenton, Douglas, Taper, John, Presgrave, Peter, Butler, Jason, Mollee, Peter, Kannourakis, George, Steer, Christopher

Source: Blood Advances; November 2024, Vol. 8 Issue: 21 p5674-5682, 9p

CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL)

Authors: Kahl, Brad S. ¹, Giannopoulos, Krzysztof ^{2, 3}, Jurczak, Wojciech ⁴, Šimkovič, Martin ^{5, 6}, Shadman, Mazyar ^{7, 8}, Österborg, Anders ^{9, 10}, Laurenti, Luca ¹¹, Walker, Patricia ¹², Opat, Stephen ^{13, 14}, Chan, Henry ¹⁵, Ciepluch, Hanna ¹⁶, Greil, Richard ^{17, 18, 19}, Tani, Monica ²⁰, Trnéný, Marek ²¹, Brander, Danielle M. ²², Flinn, Ian W. ²³, Grosicki, Sebastian ²⁴, Verner, Emma ^{25, 26}, Brown, Jennifer R. ²⁷, Ghia, Paolo ²⁸, Li, Jianyong ²⁹, Tian, Tian ³⁰, Zhou, Lei ³⁰, Marimpietri, Carol ³⁰, Paik, Jason C. ³⁰, Cohen, Aileen ³⁰, Robak, Tadeusz ³¹, Hillmen, Peter ³², Tam, Constantine S. ^{33, 34, 35, 36}

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S269-S270

CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data

Authors: Soumerai, Jacob D. ¹, Opat, Stephen ^{2, 3}, Cheah, Chan Y. ^{4, 5, 6}, Lasica, Masa ⁷, Verner, Emma ^{8, 9}, Browett, Peter J. ¹⁰, Chan, Henry ¹¹, Barca, Eva González ¹², Hilger, James ¹³, Fang, Yiqian ¹³, Simpson, David ¹³, Tam, Constantine S. ^{14, 15, 16}

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S267-S268

A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.

Authors: Odutola, Michael K., van Leeuwen, Marina T., Bruinsma, Fiona, Turner, Jennifer, Hertzberg, Mark, Seymour, John F., Prince, H. Miles, Trotman, Judith, Verner, Emma, Roncolato, Fernando, Opat, Stephen, Lindeman, Robert, Tiley, Campbell, Milliken, Samuel T., Underhill, Craig R., Benke, Geza, Giles, Graham G., Vajdic, Claire M.

Source: Cancer Epidemiology, Biomarkers & Prevention; Jan2024, Vol. 33 Issue 1, p106-116, 11p

Sequoia: Results of a Phase 3 Randomized Study of Zanubrutinib (Zanu) Versus Bendamustine + Rituximab (BR) in Patients (Pts) with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors: Shadman, Mazyar, Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M., Flinn, Ian W., Grosicki, Sebastian, Verner, Emma, Brown, Jennifer R., Kahl, Brad S., Ghia, Paolo, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C., Cohen, Aileen, Huang, Jane, Robak, Tadeusz, Hillmen, Peter, Tam, Constantine S.

Source: Transplantation and Cellular Therapy. 28(S):S478-S479

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157888402.0x000001&indx=1&recIds=ETOCvdc_100157888402.0x000001

Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study.

Authors: Odutola, Michael K., van Leeuwen, Marina T., Bruinsma, Fiona J., Benke, Geza, Turner, Michelle C., Trotman, Judith, Turner, Jennifer, Seymour, John F., Prince, H. Miles, Milliken, Samuel T., Tiley, Campbell, Hertzberg, Mark, Roncolato, Fernando, Opat, Stephen, Lindeman, Robert, Verner, Emma, Underhill, Craig R., Cardis, Elisabeth, Giles, Graham, Vajdic, Claire M.

Source: Occupational & Environmental Medicine; Oct2023, Vol. 80 Issue 10, p599-602, 4p

A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with Non-Hodgkin Lymphoma (NHL) or Waldenström Macroglobulinemia (WM): Preliminary Data

Authors: Soumerai, Jacob D., Lasica, Masa ^*, Opat, Stephen, Cheah, Chan Y., Chan, Henry, Verner, Emma ^*, González Barca, Eva ^*, Tedeschi, Alessandra ^*, Hilger, James ^*, Fang, Yiqian ^*, Simpson, David ^*, Tam, Constantine S. ^*

Source: In Blood 15 November 2022 140 Supplement 1:9325-9327

A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with CLL/SLL: Preliminary Data

Authors: Cheah, Chan Y., Tam, Constantine S. ^*, Lasica, Masa ^*, Verner, Emma ^*, Browett, Peter J., Anderson, Mary Ann ^*, Hilger, James ^*, Fang, Yiqian ^*, Simpson, David ^*, Opat, Stephen

Source: In Blood 15 November 2022 140 Supplement 1:2321-2323

Poster: CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data

Authors: Soumerai, Jacob D., Opat, Stephen, Cheah, Chan Y., Lasica, Masa, Verner, Emma, Browett, Peter J., Chan, Henry, Barca, Eva González, Hilger, James, Fang, Yiqian, Simpson, David, Tam, Constantine S.

Source: Clinical lymphoma, myeloma & leukemia. 22(S2):S140-S140

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172885056.0x000001&indx=1&recIds=ETOCvdc_100172885056.0x000001

Poster: CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors: Kahl, Brad S., Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Shadman, Mazyar, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M., Flinn, Ian W., Grosicki, Sebastian, Verner, Emma, Brown, Jennifer R., Ghia, Paolo, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C., Cohen, Aileen, Robak, Tadeusz, Hillmen, Peter, Tam, Constantine S.

Source: Clinical lymphoma, myeloma & leukemia. 22(S2):S139-S139

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172885078.0x000001&indx=1&recIds=ETOCvdc_100172885078.0x000001

The Genetic Landscape in Elderly DLBCL Aged > 75 Years in the Australasian Leukaemia & Lymphoma Group NHL29 Iric Trial Identifies New Targetable Mutations

Authors: Rijal, Sewa ^*, Lim, Jun Hee ^*, Smyth, Lillian ^*, Coombes, Caitlin ^*, Jain, Sanjiv ^*, Saxena, Kartik ^*, Trotman, Judith, Verner, Emma ^*, Gandhi, Maher K., Gandhi, Kaushal ^*, Talaulikar, Dipti

Source: In Blood 5 November 2020 136 Supplement 1:18-20

Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)

Authors: Wei, Andrew H, Kennedy, Glen A ^*, Morris, Kirk L, Grigg, Andrew ^*, He, Simon ^*, Schwarer, Anthony ^*, Ting, Stephen B ^*, Enjeti, Anoop Kumar, Yuen, Sam, D'Rozario, James, Latimer, Maya ^*, Marlton, Paula, Bilmon, Ian ^*, Taper, John ^*, Cull, Gavin, Tiley, Campbell ^*, Verner, Emma ^*, Hahn, Uwe H ^*, Hiwase, Devendra K, Iland, Harry ^*, Murphy, Nichloas ^*, Ravanathan, Sundra ^*, Nguyen, Uyen ^*, Ong, Doen Ming ^*, Loo, Sun ^*, Tiong, Ing-Soo ^*, Wall, Meaghan ^*, Anstee, Natasha S ^*, Levis, Mark, Murray, Michael ^*, Rawling, Tristan ^*, Leadbetter, Joanna ^*, Bajel, Ashish, Roberts, Andrew W

Source: In Blood 5 November 2020 136 Supplement 1:36-38

Monotherapy with Second-Generation BCL2 Inhibitor Sonrotoclax (BGB-11417) Is Well Tolerated with High Response Rates in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Data from an Ongoing Phase 1 Study

Authors: Tedeschi, Alessandra, Cheah, Chan Yoon, Opat, Stephen S., Verner, Emma, Magnano, Laura, Epperla, Narendranath, Hilger, James, Fang, Yiqian, Simpson, David, Guo, Haiyi, Anderson, Mary Ann

Source: In Blood 2 November 2023 142 Supplement 1:3032-3032